NovaLisa® SARS-CoV-2 IgM 96 det.

The NovaLisa^® SARS-CoV-2 IgM ELISA kit is intended for the qualitative detection of IgM class antibodies to SARS-CoV-2 virus in human serum and plasma for diagnostics of exposure to coronavirus (COVID-19). The assay is CE-IVD marked The ELISA antibody detection assays are an ideal supplement for the direct pathogen detection and are a valuable tool for epidemiological studies.

Assay Features

• Separate Detection of IgM antibodies
• SARS-CoV-2 Nucleocapsid recombinant antigen
• Ideal complement to RT-PCR
• Ready-to-use controls
• Results in 2 hours
• Assay procedure is easy to automate
• Works on any open ELISA system (protocols available)
• CE-IVD